HRTX is currently covered by 2 analysts with an average price target of $6. This is a potential upside of $5.75 (2300%) from yesterday's end of day stock price of $0.25.
Heron Therapeuti's activity chart (see below) currently has 62 price targets and 53 ratings on display. The stock rating distribution of HRTX is 100% BUY.
Analysts' price targets on this stock were met 37.15% of the time, taking 140 days on average.
Highest price target for HRTX is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by BRANDON FOLKES from CANTOR FITZGERALD on 09-Jan-2026. First documented stock forecast 15-May-2015.
Currently out of the existing stock ratings of HRTX, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Sep-2018
$6
$4.79 (395.87%)
$6
10 months 11 days ago
(09-Jan-2026)
0/10 (0%)
$4.61 (331.65%)
Buy Since 18-Jan-2022
$5
$23
1 years 16 days ago
(04-Nov-2025)
0/2 (0%)
$3.86 (338.60%)
Buy Since 27-Feb-2017
$4
$4
1 years 7 months 9 days ago
(11-Apr-2025)
2/32 (6.25%)
$2.09 (109.42%)
216
Buy Since 10-Dec-2015
$9
$9
2 years 6 months 4 days ago
(16-May-2024)
1/5 (20%)
$5.78 (179.50%)
268
Buy Since 26-Jun-2015
$2.5
$7.5
3 years 6 days ago
(15-Nov-2023)
5/19 (26.32%)
$1.64 (190.70%)
254
What is HRTX (Heron Therapeuti) average time for price targets to be met?
Which analyst most recently updated their price target on HRTX (Heron Therapeuti)?
Which analyst has the most public recommendations on HRTX (Heron Therapeuti)?
Which analyst is the currently most bullish on HRTX (Heron Therapeuti)?
Which analyst is the currently most reserved on HRTX (Heron Therapeuti)?